In 1969, a pharmacologist named Tu Youyou was called into a room. There was no fanfare or press release. Just a quiet order, passed down from the government. At the time, that same government was falling apart at home, even while it tried to help an ally win a war overseas.
Picture the backdrop for a second. China was in the thick of the Cultural Revolution. Scientists were being sent off to work farms. Universities had basically stopped functioning. And somehow, in the middle of all that chaos, Mao Zedong and Premier Zhou Enlai gave the quiet go-ahead for one of the most ambitious medical missions of the century. They called it Project 523. The name came from the day it started, May 23, 1967. The reason it even existed was Ho Chi Minh. North Vietnam's soldiers weren't just dying from combat; they were dying from a mosquito-borne parasite that had figured out how to dodge every drug thrown at it. Zhou asked Mao for help, the mass project got the green light to keep their allies' troops combat-ready, and China ended up pulling in more than 500 scientists. Sixty institutions, working across the country, all chasing the same problem.
Sit with that number for a second. Five hundred people. Sixty places. One goal.
Early in 1969, Tu was put in charge of the Project 523 team at her institute. There, people trained in traditional medicine worked side by side with modern chemists. She was 39 years old at the time. No doctorate. Never studied abroad. Even now, she's the only Chinese scientist to win a Nobel in a scientific category without a PhD, a medical degree, or foreign training behind her. On paper, she's an odd pick to run something this big. Turns out she was exactly the right one.
A Trip to the Rainforest, Then Straight Back to the Books
Soon after taking charge, Tu went to Hainan Island, down in southern China, where malaria was ripping through entire communities. She wasn't reading about the disease in a report anymore. She was standing in the wards watching what it actually does to a person's body. That's a very different kind of information to carry back with you.
So when she got back to Beijing, she did something that sounds almost old-fashioned for a project this massive. She went digging through ancient Chinese medical texts. Centuries-old stuff, full of remedies for what they used to call "intermittent fevers," which is really just an old name for a malaria symptom. Her team went through more than 2,000 of these old recipes and whittled them down to 640 worth a closer look.
One plant kept popping up, over and over: sweet wormwood, or qinghao. Only problem, every time they extracted it the normal way, by boiling it, the results made no sense. Worked on some mice, did nothing on others. For a project already years deep into testing, that's the kind of wall that quietly ends things.
Instead of tossing the plant aside, Tu went back even further. To a text more than a thousand years old.
The One Line That Changed Everything
The text was called Emergency Prescriptions Kept Up One's Sleeve, written by a physician named Ge Hong sometime between 284 and 346 AD. Buried in it was one plain, almost boring instruction. Take a handful of qinghao, soak it in two litres of water, wring it out, drink the juice.
Most people skim right past a line like that. Tu didn't. She caught the word "soak." Not boiled. Not steeped over a fire. Soaked, which meant cold water. And it clicked for her: maybe the heat was the whole problem. Maybe boiling the plant was killing off whatever made it work in the first place. So she reworked the process from scratch, eventually landing on a cold, low-temperature ether extraction instead of water. And just like that, the wild, inconsistent results turned steady.
Say that out loud and it almost sounds too easy. A sentence nearly seventeen hundred years old, read a little more carefully than anyone before her had bothered to, cracked a problem modern chemistry had been circling for years. But honestly, that's how a lot of real breakthroughs go. Not some lightning bolt of genius. Just somebody willing to take an old, half-forgotten clue seriously when everyone else had already filed it away as folklore.
On October 4, 1971, her team finally hit on an extraction that worked. Sample 191. It wiped out malaria in infected mice completely. Then it worked on monkeys too. And that's where the story takes the turn people actually remember.
She Went First
Before any new drug can reach a patient, someone has to find out what it does to a human body. Normally that means months, sometimes years, of ethics boards and animal data and layers of caution. Tu didn't really have that kind of time. Not inside a secretive project running under wartime pressure.
So she did the only thing that made sense to her. She took it herself first. As the person leading the group, she felt that responsibility belonged to her, not to somebody else on her team. In August 1972, she led a trial team to Hainan Island and tested the extract on 21 patients, but only after she'd already taken it herself to make sure it wouldn't hurt anyone.
Nothing happened to her. No bad reaction. That's it, that's the whole sentence, and it's almost too quiet for what it actually represents. Somewhere in a woman is sitting with real uncertainty, not knowing what was about to happen inside her own body, and coming out the other side fine. The trials that followed showed effectiveness between 95 and 100 per cent. They named the compound artemisinin.
Decades of Silence, Then a Stage in Stockholm
Here's the part that usually gets skipped over. Because Project 523 was classified, none of Tu's work got published under her own name for years. Nothing about the project reached the public until 1978, when the Guangming Daily finally ran an official account, and that's really the moment her name started travelling past the walls of the project.
Then in 2015, something unusual happened. Tu won the Nobel Prize in Physiology or Medicine, sharing it with William C. Campbell and Satoshi Ōmura. She became the first Chinese Nobel laureate in that category, and the first female citizen of the People's Republic of China to win a Nobel Prize in anything at all.
But the real twist is that the prize for the malaria breakthrough went to one name. Hers. For work that, by every honest account, ran through hundreds of hands. To be clear, Chinese researchers have never really disputed that Tu played the decisive role. But a lot of them have also pointed out, fairly, that people like Li Guoqiao, who ran the clinical trials, or Luo Zeyuan, whose team pulled the first pure artemisinin crystals at scale, deserve some of that spotlight too.
And that's really where this stops being a story about one woman and a plant. It turns into a bigger question about how two very different scientific cultures tell the story of a discovery.
One Name, Five Hundred Hands
The West loves a lone genius. The scientist alone at midnight who sees what nobody else could. Makes for a great magazine cover. Fits neatly on a textbook page.
China's approach to Project 523 was built to work almost the opposite way, on purpose. Dozens of institutions are screening thousands of compounds side by side, sharing results across teams that weren't even allowed to talk about the project outside their own walls. Tu's insight, that cold water detail, was hers and hers alone. But the extraction after that, the crystallisation, the structural work, scaling it up for real clinical use, all of that ran through other labs and other people across the country.
So when the Nobel committee handed the credit to one person, it wasn't exactly wrong. It just borrowed a Western lens to describe something that was never built that way to begin with. The real answer probably sits somewhere in the middle, one person's spark and hundreds of people's grind, and honestly, neither half of that story means much without the other.
Tu Youyou never set out to become the face of anything. She just asked a stubborn question about a sentence written fourteen centuries before she was born. She tested her hunch on her own body before she asked anyone else to. Then she waited decades for the world to catch up to something she'd already proven true. Somewhere in that gap, between 1972 and 2015, is a quiet reminder. Good work can sit unclaimed for a long, long time. That never says anything about whether it mattered.
References:
- World Health Organisation, "From 30 million cases to zero: China is certified malaria-free by WHO": https://www.who.int
- NobelPrize.org, "Tu Youyou" https://www.nobelprize.org
- Wikipedia, "Tu Youyou":https://en.wikipedia.org/wiki/Tu_Youyou
- Wikipedia, "Project 523": https://en.wikipedia.org/wiki/Project_523
- Lasker Foundation, "Artemisinin therapy for malaria": htps://laskerfoundation.org
- PNAS, "Profile of William C. Campbell, Satoshi Ōmura, and Youyou Tu, 2015 Nobel Laureates in Physiology or Medicine": https://www.pnas.org/doi/10.1073/pnas.1520952112
- Journal of Clinical Investigation, "From branch to bedside: Youyou Tu is awarded the 2011 Lasker~DeBakey Clinical Medical Research Award": htts://www.jci.org/articles/view/60887
- EF Tours Blog, "Tu Youyou: an excerpt from Nobel Journeys": http://blog.eftours.com/article/nobel-journeys-tu-youyou/
- Lindau Nobel Laureate Meetings, "The Modest Nobel Laureate: Youyou Tu" - https://www.lindau-nobel.org
- IBSA Foundation, "Tu Youyou, the Nobel Prize for her work on malaria" https//www.ibsafoundation.org